000			02001 a2200541 4500
005			20250516054949.0
264		0	_c20120328
008			201203s 0 0 eng d
022			_a1555-8576
024	7		_a10.4161/cbt.12.7.18059 _2doi
040			_aNLM _beng _cNLM
100	1		_aKline, Christina Leah
245	0	0	_aPreliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients. _h[electronic resource]
260			_bCancer biology & therapy _cOct 2011
300			_a557-68 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntimetabolites, Antineoplastic _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aArea Under Curve
650	0	4	_aCamptothecin _xanalogs & derivatives
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aLeucovorin _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganoplatinum Compounds _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins B-raf _xgenetics
650	0	4	_aProto-Oncogene Proteins p21(ras)
650	0	4	_aThymidylate Synthase _xgenetics
650	0	4	_aras Proteins _xgenetics
700	1		_aSheikh, Hassan S
700	1		_aScicchitano, Angelique
700	1		_aGingrich, Rebecca
700	1		_aBeachler, Cheryl
700	1		_aFinnberg, Niklas K
700	1		_aLiao, Jason
700	1		_aSivik, Jeffrey
700	1		_aEl-Deiry, Wafik S
773	0		_tCancer biology & therapy _gvol. 12 _gno. 7 _gp. 557-68
856	4	0	_uhttps://doi.org/10.4161/cbt.12.7.18059 _zAvailable from publisher's website
999			_c21169734 _d21169734